Cover Image

Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison

Background: The previously approved botulinum toxin and nowadays promising calcitonin gene-related peptide (CGRP) monoclonal antibody have shown efficacy for preventing chronic migraine (CM). However, there is no direct evidence for their relative effectiveness and safety. In this study, we conducte...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiajie Lu (Author), Quanquan Zhang (Author), Xiaoning Guo (Author), Wei Liu (Author), Chunyang Xu (Author), Xiaowei Hu (Author), Jianqiang Ni (Author), Haifeng Lu (Author), Hongru Zhao (Author)
Format: Book
Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items